ICD-10 Coding for Acute Leukemia(C91.0, C91.0A, C91.0N)
Comprehensive guide on ICD-10 coding for acute leukemia, including documentation requirements and coding pitfalls.
Complete code families applicable to Acute Leukemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C91.0 | Acute lymphoblastic leukemia [ALL] | Use for confirmed cases of ALL with specified lineage. |
|
| C92.0 | Acute myeloblastic leukemia [AML] | Use for confirmed cases of AML with specified genetic markers. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAcute Leukemia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Acute Leukemia.
Failure to document genetic markers for AML
Impact
Clinical: Inaccurate treatment planning., Regulatory: Potential audit issues., Financial: Incorrect DRG assignment.
Mitigation
Ensure genetic testing is documented., Include results in patient records.
Using Z85.6 for active leukemia cases
Impact
Reimbursement: Incorrect DRG assignment leading to reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use C91.0- or C92.0- for active disease.
Incorrect use of remission status codes
Impact
Using remission codes without proper documentation.
Mitigation
Ensure remission status is clearly documented in the medical record.